Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion type Assertion NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_head.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion description "[These data suggest that CrkI/p130(Cas) could be exploited as potential molecular therapeutic target for prostate cancer metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_provenance.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion evidence source_evidence_literature NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_provenance.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion SIO_000772 22144090 NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_provenance.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion wasDerivedFrom befree-20140225 NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_provenance.
- NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_assertion wasGeneratedBy ECO_0000203 NP339001.RALvOGZoD_MLbsUNx0kPBWgD1Eq6dNWaTHDAorKzk4eK0130_provenance.